Gene therapy—where are we?
- 1 July 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354, S1-S4
- https://doi.org/10.1016/s0140-6736(99)90240-4
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma AntigensJNCI Journal of the National Cancer Institute, 1998
- Liposome-based gene therapyPharmaceutical Science & Technology Today, 1998
- Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple speciesNature Medicine, 1997
- Long-TermIn VivoExpression of the MFG-ADA Retroviral Vector in Rhesus Monkeys Transplanted with Transduced Bone Marrow CellsHuman Gene Therapy, 1997
- Genetic prodrug activation therapyMolecular Medicine Today, 1997
- Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the LungHuman Gene Therapy, 1996
- Molecular Analysis of T Lymphocyte-Directed Gene Therapy for Adenosine Deaminase Deficiency: Long-Term ExpressionIn Vivoof Genes Introduced with a Retroviral VectorHuman Gene Therapy, 1996
- Current status of CF gene therapyTrends in Genetics, 1996
- VIRAL VECTORS IN GENE THERAPYAnnual Review of Microbiology, 1995
- Gene TherapyScientific American, 1990